ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Societe Generale Effekten

Societe Generale Effekten (S27877)

0.00
0.00
( 0.00% )

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

S27877 Noticias

Solo noticias oficiales
Se encontraron 0 artículos
Monksdream Monksdream 4 minutos hace
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus
Invest-in-America Invest-in-America 4 minutos hace
LIPO: Float so tiny, put it in your back pocket.
LIPO
t1215s t1215s 4 minutos hace
Good morning people, Suzuki And yet you are here ,looking for an empty padded cell lol

GoGoooooCOOP GLTA
Have a great day people -Ts 😉
COOP
SC8 SC8 5 minutos hace
The objective of Radiogel treatment is compete death of treated tumor. Anything less is a failure, as the remaining cancer will grow and spread. As of 30 days in the one patient MK mentioned, a portion of treated tumor survives. Maybe that portion will die soon, but the only report we have from M
RDGL
dreamaker56 dreamaker56 5 minutos hace
Years ago they Issued a PR about a reverse split could never happen. Something about shares held/frozen from litigation from a previous management's lawsuit. That was the only thing helping us out at the time. Supposedly those shares will never be released so BLDV will never be able to get approv
BLDV
RIGATONI RIGATONI 5 minutos hace
~CAPR $13.95...

Looks like Blackrock increased their holdings here too, so that's ASPI and now CAPR and recently Vanguard also which is linked to this post...



SEC.gov | EDGAR Full Text


https://www.sec.gov/edgar/search/#/q=Capri
ASPI CAPR
glenn1919 glenn1919 6 minutos hace
BURU...............MULN..............................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
BURU MULN
DMC8 DMC8 6 minutos hace
https://www.sciencedirect.com/science/article/pii/S1933287425000066
AMRN
jammy32 jammy32 7 minutos hace
Unacceptable is all I can say. Nasrat owes investors updates outside of the CC. There is not reason not have PR’s from time to time.

I’m starting to really believe the scrutiny is the issue with the Nasdaq. Analyst - please explain the relationship between elite and Mikah
ELTP
trader_ron trader_ron 7 minutos hace
$ADHC American Diversifield Holdings Corporation Provides Update on Dexcom/GlucoGuard App Development Through UC Irvine MADO Program
https://www.otcmarkets.com/stock/ADHC/news/story?e&id=3125636
ADHC
trader_ron trader_ron 7 minutos hace
$ADHC American Diversifield Holdings Corporation Provides Update on Dexcom/GlucoGuard App Development Through UC Irvine MADO Program
https://www.otcmarkets.com/stock/ADHC/news/story?e&id=3125636
ADHC
Here Today Here Today 8 minutos hace
I don't believe they are a one time sale because don't forget Dr Otiko and newly hired team are almost finished getting the product fully approved an able to be shipped to the country India which everyone knows has billions of people living there and if anyone has visited there, has many areas that
VDRM
JoeMonte1 JoeMonte1 8 minutos hace
Thanks for posting, positive signals.
PSPW
QuantumMaestro53 QuantumMaestro53 8 minutos hace
To see all of the fraud, court cases and judgements, just go here and type in Kevin Lamb or Innovative Outcomes, if the link doesn't work google Arkansas CourtConnect:

https://caseinfonew.arcourts.gov/opad
UBQU
Roofus Roofus 8 minutos hace
$26.00 per share ….

Still seems low for a revolutionary cancer technology (for 18 or more types of cancer and other usages), however all of us early investors of this wonderful company and technology would certainly still be very happy to see $26 per share.
RDGL
tedpeele tedpeele 11 minutos hace
I got out - like the news quite a bit though - hope you do well!

I guess traders looked and saw the registration as well as the reverse split and decided to play it only very quick?



..
EDBL
JSmith5 JSmith5 11 minutos hace
The calculation of the share price is much simpler: if 7.2 billion shares (warrants redeemed) are worth 250 billion dollars, then one share is worth 34.72 USD. Such an approach also avoids confusion regarding a JPS conversion.

Thanks Fully Diluted - agree. Also, this would align pret
FNMA
TAKURI TAKURI 12 minutos hace
pps 0.0765 / 1500(rs) = 0,000051 real pps
RGBP
glenn1919 glenn1919 12 minutos hace
PEV......CAPT.....BURU........MULN.....................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
BURU MULN PEV
glenn1919 glenn1919 13 minutos hace
CGC.....ZNTL......RZLV.......EZGO....................https://stockcharts.com/h-sc/ui?s=EZGO&p=D&yr=0&mn=3&dy=0&id=p11960084343
EZGO RZLV ZNTL
RIGATONI RIGATONI 13 minutos hace
Small floater here around 1.2M with decent news too..

MGRX $3.17

https://www.globenewswire.com/news-release/2025/02/06/3021893/0/en/Mangoceuticals-Advances-H1N1-Efficacy-Study-Noting-Significant-Reduction-in-Viral-Load-in-Phase-1-Studies-and-Engages-Vipragen-Bioscienc
MGRX
Fully Diluted Fully Diluted 13 minutos hace
Hi stink stack,

Hopeful investor makes no predictions. But I suspect that an NYSE uplisting will only make sense once the SPS have been devalued. Or converted into commons, but Bessent certainly doesn't want any stink stacks in his backyard, does he? 😁
FNMA
tkg tkg 14 minutos hace
TOP Telecommunications, Optics & Photonics
Conference 2025
25-26 February 2025
The Kia Oval, London, UK

Stream 5: Photonics Components

Modulator and Receiver PICs for High Data Rate Optical Networks
Daniel Jalo, Lumentum
https://topcon
LWLG
SC8 SC8 14 minutos hace
Never said anything of kind. Just made the safe assumption the one patient MK is crowing about, that sadly still has cancer btw, was the best result of the 5. And yes, this would hardly be the first time MK jumped the gun on a result. Remember when he lied in 2023 that the rabbit testing had succ
RDGL
antihama antihama 15 minutos hace
Per the last quarterly a new IND will be needed and if that's the case they'll need to run a Phase 1/2 trial 1st but remember w surrogate endpoints w shorter times to get AA than it would take w OS as an endpoint. As far as manufacturing Direct, they wouldn't be using Eden but TFF as hyperopia expla
BCG CMC

Su Consulta Reciente

Delayed Upgrade Clock